Merck (MRK) Long-Term Debt Repayments (2009 - 2026)

Merck (MRK) has 17 years of Long-Term Debt Repayments data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Long-Term Debt Repayments fell 54.4% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 62.39% YoY) and the FY2025 annual result came in at $2.5 billion, up 94.03% from the prior year.
• Long-Term Debt Repayments improved to $1.1 billion in Q1 2026 per MRK's latest filing, from $2.0 million in the prior quarter.
• Across five years, Long-Term Debt Repayments topped out at $2.5 billion in Q1 2025 and bottomed at $1.0 million in Q4 2022.
• The 5-year median for Long-Term Debt Repayments is $539.0 million (2024), against an average of $687.6 million.
• The widest annual swing landed in 2023, when Long-Term Debt Repayments sank 99.92%; it then surged 75000.0% in 2024.
• Tracing MRK's Long-Term Debt Repayments over 5 years: stood at $1.0 million in 2022, then surged by 200.0% to $3.0 million in 2023, then jumped by 17866.67% to $539.0 million in 2024, then sank by 99.63% to $2.0 million in 2025, then soared by 56900.0% to $1.1 billion in 2026.
• Per Business Quant, the three latest MRK Long-Term Debt Repayments figures stand at $1.1 billion (Q1 2026), $2.0 million (Q4 2025), and $1.0 million (Q3 2025).

Peer Comparison